Wow!
Med Tech giant BD (Becton - Dickinson) also in on a $115 million private placement for Vicarious, among other very high profile investors...
“The SPAC deal’s total also includes a $115 million private investment round that has attracted the medtech giant BD as well as Vicarious’ previous high-profile backers, including Bill Gates, Khosla Ventures, Innovation Endeavors and E15 VC. After the acquisition closes in the third quarter, the company will emerge on the NYSE with the surprisingly unclaimed ticker RBOT, and eyes on a late 2023 commercial launch.”